Chan Lee
Fortuna: 22 M $ al 31/08/2026
Fortuna: 22 M $ al 31/08/2026
Chan Lee is currently Secretary, Senior Vice President & General Counsel at BeOne Medicines Ltd. since 2022.
Formerly, Mr. Lee was General Counsel-North America Specialty Care at Sanofi from 2016 to 2022 and Chief Counsel-Innovative Health at Pfizer Inc. in 2016.
Education includes undergraduate studies at Cornell University and graduate studies at the University of California, Berkeley.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 30/07/2026 | 325.312 ( 0,28 % ) | 13 M $ | 31/08/2026 | |
BEONE MEDICINES LTD. 0,02 % | 11/08/2026 | 325.312 ( 0,02 % ) | 9 M $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| BEIGENE LTD | Consejero General | 18/07/2022 |
| Empresas | Cargo | Fin |
|---|---|---|
| SANOFI | Corporate Officer/Principal | 01/07/2022 |
| PFIZER INC. | Corporate Officer/Principal | 01/06/2016 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Sanofi
Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Berkeley
University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BeiGene Ltd.
BeiGene Ltd. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.